Citations Report

Clinical Investigation : Citations & Metrics Report

Articles published in Clinical Investigation have been cited by esteemed scholars and scientists all around the world.

Clinical Investigation has got h-index 25, which means every article in Clinical Investigation has got 25 average citations.

Following are the list of articles that have cited the articles published in Clinical Investigation.

  2021 2020 2019 2018 2017

Year wise published articles

60 28 19 22 19

Year wise citations received

231 169 96 67 60
Journal total citations count 2998
Journal impact factor 2.21
Journal 5 years impact factor 2.17
Journal cite score 13.6644295
Journal h-index 25
Journal h-index since 2018 20
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
  • AlemdaroÄŸlu Ä°, Karaduman A, Ä°yigün-Yatar G, Tunca-Yılmaz Ö, TopaloÄŸlu H. (2014) Turkish version of the Egen Klassifikation scale version 2: validity and reliability in the Turkish population. The Turkish journal of pediatrics ;56:643-50. View at Publisher | View at Google Scholar | View at Indexing
  • Furihata T, Matsumoto S, Fu Z, Tsubota A, Sun Y, et al. (2014) Different interaction profiles of direct-acting anti-hepatitis C virus agents with human organic anion transporting polypeptides. Antimicrobial agents and chemotherapy 58: 4555-4564. View at Publisher | View at Google Scholar | View at Indexing
  • Furihata T, Fu Z, Suzuki Y, Matsumoto S, Morio H, et al. (2015 ) Differential inhibition features of direct-acting anti-hepatitis C virus agents against human organic anion transporting polypeptide 2B1. International journal of antimicrobial agents 46: 381-388. View at Publisher | View at Google Scholar | View at Indexing
  • Messina S, Vita GL, Sframeli M, Mondello S, Mazzone..et,al. (2016) Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study. Neuromuscular Disorders ;26:189-196.

    View at Publisher | View at Google Scholar
  • Lee HN, Sawnani H, Horn PS, Rybalsky I, Relucio L, Wong BL. (2016)The Performance of the Upper Limb scores correlate with pulmonary function test measures and Egen Klassifikation scores in Duchenne muscular dystrophy. Neuromuscular Disorders ;26:264-271.

    View at Publisher | View at Google Scholar
  • Cockerell CJ (2015) Counterpoint: The “dysplastic” nevus. Journal of the American Academy of Dermatology 73: 515-517. View at Publisher | View at Google Scholar | View at Indexing
  • Nathalie Goemans, Janbernd Kirschner, Eugenio Mercuri (2014) New Perspectives in the Management of Duchenne Muscular Dystrophy European Neurological Review:78–

    View at Publisher | View at Google Scholar
  • Berger VW (2015 ) Conflicts of interest, selective inertia, and research malpractice in randomized clinical trials: an unholy trinity. Science and engineering ethics 21: 857-874. View at Publisher | View at Google Scholar | View at Indexing
  • Berger VW (2016) Sequence Generation and Allocation Concealment. Journal of Evidence-Based Dental Practice 16: 145-146. View at Publisher | View at Google Scholar | View at Indexing
  • Liang Y, Chen S, Zhu J, Zhou X, Yang C, Yao L, Zhang C.(2015) Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies. Bosnian Journal of Basic Medical Sciences :42. View at Publisher | View at Google Scholar | View at Indexing
  • Faggion CM (2016) Reply to Sequence Generation and Allocation Concealment. Journal of Evidence-Based Dental Practice 16: 146. View at Publisher | View at Google Scholar | View at Indexing
  • Wang Y, Bello L, Wang Y, McDonald CM, Hoffman EP, Yu G. (2014)Predicting age at loss of ambulation in Duchenne muscular dystrophy with deep phenotypic measures. InSignal and Information Processing (GlobalSIP), 2014 IEEE Global Conference. IEEE.1344-1347 View at Publisher | View at Google Scholar | View at Indexing
  • Alonso A, Bigirumurame T, Burzykowski T, Buyse M, Molenberghs G, et al. (2016) Applied Surrogate Endpoint Evaluation Methods with SAS and R.

    View at Publisher | View at Google Scholar
  • Gloss D.(2016) Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy.American Academy of Neurology. View at Publisher | View at Google Scholar | View at Indexing
  • Whittle SB, Williamson KC, Russell HV. Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma. Pediatric hematology and oncology. 2017 Jul 4;34(5):331-42. View at Publisher | View at Google Scholar | View at Indexing
  • Anand A, Tyagi R, Mohanty M, Goyal M, De Silva KR, Wijekoon N. (2015) Dystrophin induced cognitive impairment: mechanisms, models and therapeutic strategies. Annals of neurosciences :108. View at Publisher | View at Google Scholar | View at Indexing
  • Uzdensky AB. Apoptosis regulation in the penumbra after ischemic stroke: expression of pro-and antiapoptotic proteins. Apoptosis. 2019 Oct;24(9):687-702. View at Publisher | View at Google Scholar | View at Indexing
  • Koppaka S. Imaging biomarkers for Duchenne muscular dystrophy (Doctoral dissertation, Massachusetts Institute of Technology). View at Publisher | View at Google Scholar | View at Indexing
  • Simarro PP, Cecchi G, Franco JR, Paone M, Diarra A (2015) Monitoring the progress towards the elimination of gambiense human African trypanosomiasis. PLoS Negl Trop Dis. 9: e0003785 View at Publisher | View at Google Scholar | View at Indexing
  • Loehr JA, Stinnett GR, Hernándezâ€ÂRivera M, Roten WT, Wilson LJ, Pautler RG, Rodney GG.(2016) Eliminating Nox2 reactive oxygen species production protects dystrophic skeletal muscle from pathological calcium influx assessed in vivo by manganeseâ€Âenhanced magnetic resonance imaging. The Journal of physiology;594:6395-405. View at Publisher | View at Google Scholar | View at Indexing
  • Iwamoto T, Fujisawa T, Shien T, Araki K, Sakamaki K, Sangai T, Kikawa Y, Takao S, Nishimura R, Takahashi M, Aihara T. The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs. Breast Cancer. 2020 Sep;27(5):973-81. View at Publisher | View at Google Scholar | View at Indexing
  • Носко АС, Куренков АЛ, Никитин СС, Зыков ВП. Адекватный менеджмент пациентов с дистрофинопатиями (мышечная дистрофия Дюшенна/Беккера): применение объективизирующих шкал и дополнительных методов исследования. Нервно-мышечные болезни. 2014.

    View at Publisher | View at Google Scholar
  • Chlebowski RT. Current concepts in breast cancer chemoprevention. Pol Arch Med Wewn. 2014 Jan 1;124(4):191-9. View at Publisher | View at Google Scholar | View at Indexing
  • Rugo HS. Dosing and safety implications for oncologists when administering everolimus to patients with hormone receptor-positive breast cancer. Clinical breast cancer. 2016 Feb 1;16(1):18-22. View at Publisher | View at Google Scholar | View at Indexing
  • 史惟, 李惠, 苏怡, 陆恺, 侯芳华, 杨红. 定量等长肌力测定在 Duchenne åž‹å’Œ Becker 型肌营养不良症患儿下肢肌力测定中的信度评价. 中国现代神经疾病杂志. 2015;5:018.

    View at Publisher | View at Google Scholar
  • Brufsky AM. Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer. Clinical Medicine Insights: Oncology. 2015 Jan;9:CMO-S31586. View at Publisher | View at Google Scholar | View at Indexing
  • Riseberg D. Treating Elderly Patients With Hormone Receptor–Positive Advanced Breast Cancer. Clinical Medicine Insights: Oncology. 2015 Jan;9:CMO-S26067. View at Publisher | View at Google Scholar | View at Indexing
  • Lucca SA, Petean EB. Fatherhood: experiences of fathers of boys diagnosed with Duchenne Muscular Dystrophy. Ciência & Saúde Coletiva. 2016 Oct;21(10):3081-9. View at Publisher | View at Google Scholar | View at Indexing
  • Gradishar WJ (2016) Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. Cancer Management and Research 8: 85.

    View at Publisher | View at Google Scholar
  • Казахстан Р. КЛИНИЧЕСКИЙ ПРОТОКОЛ ДИАГНОСТИКИ И ЛЕЧЕНИЯ ПРОГРЕССИРУЮЩАЯ МЫШЕЧНАЯ ДИСТРОФИЯ ДЮШЕННА/БЕККЕРА 1. Содержание.

    View at Publisher | View at Google Scholar
  • Flick AC, Ding HX, Leverett CA, Kyne RE, Liu KK et al. (2016)Synthetic approaches to the 2014 new drugs. Bioorganic & medicinal chemistry 24: 1937-1980.

    View at Publisher | View at Google Scholar
  • Γιαννοπούλου Β, Σοφοκλέους Σ. Κλίμακες αξιολÏŒγησης σε ασθενείς με μυÏŠκή δυστροφία Duchenne.

    View at Publisher | View at Google Scholar
  • Getz KA. Examining and enabling the role of health care providers as patient engagement facilitators in clinical trials. Clinical therapeutics. 2017 Nov 1;39(11):2203-13. View at Publisher | View at Google Scholar | View at Indexing
  • AlemdaroÄŸlu I. Duchenne Musküler Distrofi'li Hastalarda Dinamik Kol Egzersizinin Üst Ekstremite Fonksiyonlarına ve Genel Performansa Etkisi.

    View at Publisher | View at Google Scholar
  • 史惟. Duchenne 型肌营养不良症运动功能评价及其临床应用研究进展. 中国现代神经疾病杂志. 2015;6:002.

    View at Publisher | View at Google Scholar
  • Arora A, O’Neill A, Crome P, Martin FC (2015) Clinical medicine and substance misuse: research, assessments and treatment. Substance use and older people 7: 35-55. View at Publisher | View at Google Scholar | View at Indexing
  • Carroll JD, Poisson S, Kim MS. (2015) Current Patient Management Issues, Clinical Trial Design Challenges, and the Pathway Forward. InPatent Foramen Ovale Springer London 95-106. View at Publisher | View at Google Scholar | View at Indexing
  • Penna GO, Bührer-Sékula S, Kerr LR, Stefani MM, Rodrigues LC, de Araújo MG, Ramos AM, de Andrade AR, Costa MB, Rosa PS, Gonçalves HD. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients. PLoS neglected tropical diseases. 2017 Jul 13;11(7):e0005725. View at Publisher | View at Google Scholar | View at Indexing
  • Wroclawski ML, Serpa-Neto A, Fonseca FL, Castro-Neves-Neto O, Pompeo AS, Machado MT, Pompeo AC, del Giglio A. (2013) Cell-free plasma DNA as biochemical biomarker for the diagnosis and follow-up of prostate cancer patients. Tumor Biology.;34:2921-297.

    View at Publisher | View at Google Scholar
  • S Bisacchi G, R Hale M. A “double-edged” scaffold: antitumor power within the antibacterial quinolone. Current medicinal chemistry. 2016 Feb 1;23(6):520-77. View at Publisher | View at Google Scholar | View at Indexing
  • Franci G, Manfroni G, Cannalire R, Felicetti T, Tabarrini O et al. (2015) Tumour cell population growth inhibition and cell death induction of functionalized 6â€Âaminoquinolone derivatives. Cell proliferation 48: 705-717. View at Publisher | View at Google Scholar | View at Indexing
  • Guerit D, Philipot D, Chuchana P, Toupet K, Brondello JM, Mathieu M, Jorgensen C, Noel D.(2013) Sox9-regulated miRNA-574-3p inhibits chondrogenic differentiation of mesenchymal stem cells. PloS one;8:e62582.

    View at Publisher | View at Google Scholar
  • Wami WM. Paediatric schistosomiasis: diagnosis, morbidity and treatment. View at Publisher | View at Google Scholar | View at Indexing
  • Niessen L, Stothard R. Equitable control of schistosomiasis and helminthiasis. The Lancet Infectious Diseases. 2016 Sep 1;16(9):990-2. View at Publisher | View at Google Scholar | View at Indexing
  • Uth K, Trifonov D.(2014) Stem cell application for osteoarthritis in the knee joint: a minireview. World J Stem Cells;6:629-636.

    View at Publisher | View at Google Scholar
  • Bustinduy AL, Stothard JR, Friedman JF. Paediatric and maternal schistosomiasis: shifting the paradigms. British medical bulletin. 2017 Sep 1:1-1. View at Publisher | View at Google Scholar | View at Indexing
  • Stothard JR, Kabatereine NB, Archer J, Al-Shehri H, Tchuem-Tchuente LA, Gyapong M, Bustinduy AL. A centenary of Robert T. Leiper's lasting legacy on schistosomiasis and a COUNTDOWN on control of neglected tropical diseases. Parasitology. 2017 Oct;144(12):1602-12. View at Publisher | View at Google Scholar | View at Indexing
  • Uth K, Trifonov D. Name of journal: World Journal of Stem Cells ESPS Manuscript NO: 12841 Columns: MINIREVIEWS Stem cell application for osteoarthritis in the knee joint: A minireview.

    View at Publisher | View at Google Scholar
  • Mutapi F. Changing policy and practice in the control of pediatric schistosomiasis. Pediatrics. 2015 Mar 1;135(3):536-44. View at Publisher | View at Google Scholar | View at Indexing
  • Wong RS. (2015) Role of stem cells in spondyloarthritis: Pathogenesis, treatment and complications. Human immunology;76:781-788. View at Publisher | View at Google Scholar | View at Indexing